Markets:

Overview

News

Currencies

International

Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

2.950 -0.070 (-2.32%)

Streaming Delayed Price Updated: 1:23 PM EDT, Mar 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

3 Value Stocks Walking a Fine Line

May 30, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know

May 27, 2025

A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +2.0%) as President Trump postponed the planned 50% tariff on European Union imports,...

Via StockStory

Reflecting On Healthcare Technology for Providers Stocks’ Q1 Earnings: Evolent Health (NYSE:EVH)

May 21, 2025

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Evolent Health (NYSE:EVH) and its peers.

Via StockStory

Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know

May 21, 2025

A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that...

Via StockStory

Topics Bonds Stocks

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock ↗

March 10, 2025

Via Benzinga

1 Healthcare Stock to Keep an Eye On and 2 to Ignore

May 16, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Economy Stocks

Expert Outlook: Evolent Health Through The Eyes Of 9 Analysts ↗

May 09, 2025

Via Benzinga

Evolent Health (NYSE:EVH) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations

May 08, 2025

Healthcare solutions company Evolent Health (NYSE:EVH) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 24.4% year on year to $483.6 million. Revenue guidance...

Via StockStory

Evolent Health (EVH) Q1 Earnings Report Preview: What To Look For

May 07, 2025

Healthcare solutions company Evolent Health (NYSE:EVH) will be announcing earnings results tomorrow after market close. Here’s what investors should know.

Via StockStory

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

1 Unprofitable Stock Worth Investigating and 2 to Question

May 05, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks

April 29, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and...

Via StockStory

Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks

April 28, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (NASDAQ:OMCL) and the best and...

Via StockStory

Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks

April 25, 2025

Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Premier (NASDAQ:PINC) and its peers.

Via StockStory

Topics Economy

Elevance Health’s (NYSE:ELV) Q1 Sales Top Estimates

April 22, 2025

Health insurance provider Elevance Health (NYSE:EVH) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 14.5% year on year to $48.77 billion. Its non-GAAP profit of $11.97...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Molina Healthcare, Encompass Health, RadNet, Evolent Health, and Ibotta Shares Are Falling, What You Need To Know

April 21, 2025

A number of stocks fell in the afternoon session after President Trump criticized the Federal Reserve's approach to interest rate cuts, warning that the pace was slow and could hinder economic growth....

Via StockStory

Topics Economy Government World Trade

Elevance Health Earnings: What To Look For From ELV

April 21, 2025

Health insurance provider Elevance Health (NYSE:EVH) will be reporting results tomorrow before market hours. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence Economy

Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers

April 17, 2025

Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

Via StockStory

Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers Stocks

April 16, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers.

Via StockStory

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

April 15, 2025

Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

Via StockStory

The Analyst Verdict: Evolent Health In The Eyes Of 16 Experts ↗

April 10, 2025

Via Benzinga

1 Growth Stock to Stash and 2 to Keep Off Your Radar

April 10, 2025

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s...

Via StockStory

Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care ↗

April 08, 2025

CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.

Via Benzinga

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

March 20, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

Via StockStory

Topics Stocks

Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR)

March 14, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers.

Via StockStory

3 Reasons to Sell EVH and 1 Stock to Buy Instead

March 07, 2025

Evolent Health has gotten torched over the last six months - since September 2024, its stock price has dropped 71.1% to $8.76 per share. This was partly due to its softer quarterly results and may have...

Via StockStory

Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect

February 23, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should know.

Via StockStory

Evolent Health (EVH) Q4 2024 Earnings Call Transcript ↗

February 21, 2025

EVH earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Evolent Health (NYSE:EVH) Misses Q4 Sales Targets

February 20, 2025

Healthcare solutions company Evolent Health (NYSE:EVH) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 16.3% year on year to $646.5 million. Next quarter’s revenue guidance...

Via StockStory

Topics Economy

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.